Follow
Owen M O'Connor
Owen M O'Connor
Verified email at bu.edu
Title
Cited by
Cited by
Year
DeLTA 2.0: A deep learning pipeline for quantifying single-cell spatial and temporal dynamics
OM O’Connor, RN Alnahhas, JB Lugagne, MJ Dunlop
PLoS computational biology 18 (1), e1009797, 2022
542022
The motility regulator flhDC drives intracellular accumulation and tumor colonization of Salmonella
V Raman, N Van Dessel, OM O’Connor, NS Forbes
Journal for ImmunoTherapy of Cancer 7, 1-16, 2019
212019
Longitudinal Single‐Cell Imaging of Engineered Strains with Stimulated Raman Scattering to Characterize Heterogeneity in Fatty Acid Production
N Tague, H Lin, JB Lugagne, OM O'Connor, D Burman, WW Wong, ...
Advanced Science 10 (20), 2206519, 2023
22023
Implantable devices for cell therapy and related methods
LE Barney, M Beauregard, G Carmona, FC Gonzalez, R Heidebrecht, ...
US Patent App. 17/280,802, 2022
12022
Implantable particles and related methods
LE Barney, M Beauregard, G Carmona, FC Gonzalez, R Heidebrecht, ...
US Patent App. 17/045,127, 2021
12021
Compositions, devices, and methods for factor vii therapy
LE Barney, M Beauregard, G Carmona, FC Gonzalez, R Heidebrecht, ...
US Patent App. 17/598,154, 2023
2023
Longitudinal single-cell chemical imaging of engineered strains reveals heterogeneity in fatty acid production
N Tague, H Lin, JB Lugagne, OM O’Connor, D Burman, WW Wong, ...
bioRxiv, 2022
2022
Compositions, devices, and methods for treating fabry disease
LE Barney, M Beauregard, G Carmona, FC Gonzalez, R Heidebrecht, ...
US Patent App. 17/598,176, 2022
2022
Correcting bleeding disorders using blood clotting factors produced in vivo by shielded engineered allogeneic cells
G Carmona, L Barney, J Sewell, R Newman, C Carroll, O O'Connor, ...
HUMAN GENE THERAPY 30 (11), A192-A192, 2019
2019
Correcting Bleeding Disorders Using Blood Clotting Factors Produced by Shielded Engineered Allogenic Cells
G Carmona, L Barney, J Sewell, R Newman, C Carroll, O O'Connor, ...
MOLECULAR THERAPY 27 (4), 338-338, 2019
2019
Enzyme Replacing Therapy in MPS-1 Mice by Enzyme Produced In Vivo by Shielded Engineered Allogeneic Cells
E Makino, B Fluharty, D Tietz, L Barney, J Sewell, C Carroll, J Huang, ...
MOLECULAR THERAPY 27 (4), 241-242, 2019
2019
Correcting hemophilia A using human FVIII produced in vivo by Afibromer (TM) shielded engineered allogeneic cells
G Carmona, L Barney, J Sewell, R Newman, C Carroll, O O'Connor, ...
HAEMOPHILIA 25, 98-98, 2019
2019
Intracellular Invasion of Salmonella Drives Tumor Colonization of the Bacteria in vitro
V Raman, N Van Dessel, O O'Connor, NS Forbes
2017 AIChE Annual Meeting, 2017
2017
Upregulation of Salmonella motility in tumors improves dispersion, colonization and intracellular invasion of the bacteria
V Raman, NV Dessel, O O'Connor, NS Forbes
Cancer Research 77 (13_Supplement), 5136-5136, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–14